Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Myricx Pharma, a UK-based small molecule inhibitor developer spun out of Imperial College London and Francis Crick Institute, obtained £4.5m ($5.9m) yesterday in a seed round involving Sofinnova Partners and Brandon Capital Partners. The company will initially target cancer via a mechanism called NMT thought to selectively kill tumour cells. Myricx will use the funding to add personnel to its R&D team with a view of progressing its assets toward initial clinical trials.

One Big Circle, a UK-based train carriage monitoring technology developer allied to Engine Shed, an incubator backed by University of Bristol, has secured an undisclosed sum from private investors David Harris and Toby Hughes, Insider Media reported yesterday. One Big Circle supplies a computer vision-powered technology to evaluate footage from train carriages and provide data insights to the operator through its cloud-based software platform. Harris and Hughes have joined the company board as executive chairman and non-executive director respectively.